Result : 115

Prion diseases

Prion diseases or subacute transmissible spongiform encephalopathies (TSE) are neurodegenerative diseases. The agent responsible for the disease and its transmission is a protein with an abnormal...
 Jean-Philippe Brandel. March 2025, page 65

Chemsex: a growing and evolving practice

Chemsex, the voluntary use of psychoactive substances to facilitate, initiate, increase, intensify or prolong sexual relations and performance, often involves multiple substance use. These include...
 Jean-Victor Blanc. March 2025, page 70

Marcel Proust and doctors

Jacques Rouëssé. March 2025, page 92

Bladder pain syndrome

Bladder pain syndrome (BPS), often associated with other pelvic pain syndromes, is defined as perceived chronic pain or discomfort related to the bladder, associated with other urinary symptoms...
 Shahed Borojeni, Benoit Peyronnet. June 2025, page 36

Irritable bowel syndrome

Irritable bowel syndrome (IBS) is a common functional digestive disorder affecting 4 to 10% of the population, with a female gender predominance. Although it is a benign disease, it can sometimes...
 Jean-Marc Sabaté. June 2025, page 48

Pelvic-perineal muscle pain syndromes

The search for muscle pain in the lower abdominal, gluteal and perineal regions is part of the systematic clinical examination of all pelvic perineal pain. These points of muscle hypersensitivity...
 Véronique Bonniaud. June 2025, page 62

Living with… Kawasaki disease

 Alexandre Belot, Raphaël Darbon. June 2025, page 87

Recent developments in the treatment of ANCA-associated vasculitides

The treatment of antineutrophil cytoplasm antibody-associated (ANCA) vasculitis is based on induction therapy to achieve remission, followed by maintenance therapy to prevent relapse. Management...
 Xavier Puéchal. November 2025, page 43

Towards more targeted therapies in the treatment of ANCA-associated vasculitides

The treatment of ANCA-associated vasculitides (AAV) is based on therapeutic strategies that achieve remission and significantly reduce the risk of relapse in most cases over the medium term....
 Alexandre Karras. November 2025, page 49

Venous diseases of the liver: what are we talking about?

Vascular diseases of the liver include damage to arterial and venous vessels, both hepatic and perihepatic. The main venous forms are Budd-Chiari syndrome (BCS), portal vein thrombosis (PVT) and...
 Audrey Payancé  ,  Juliette Soret-Dulphy . April 2026, page 22

Budd-Chiari syndrome

Budd-Chiari syndrome is a rare condition characterized by obstruction of hepatic venous drainage, ranging from hepatic venules to the terminal part of the inferior vena cava. A thorough etiological...
 Magdalena Meszaros ,  Christophe Bureau . April 2026, page 31

Portal vein thrombosis and mesenteric venous ischemia

Portal vein thrombosis (PVT) in the absence of underlying chronic liver disease is a rare disease and is frequently associated with prothrombotic factors. In patients with cirrhosis, the frequency...
 Cyprien Gayat ,  Alexandre Nuzzo  ,  Laure Elkrief  . April 2026, page 44

Special features of anticoagulant treatment in vascular liver diseases

Anticoagulants play a major role in the management of vascular liver diseases (VLD). However, their use is challenging due to portal hypertension and thrombocytopenia, frequently observed in these...
 Emmanuelle De Raucourt ,  Imen Ben Salah ,  Juliette Gay . April 2026, page 52

Sweet’s syndrome revealing pulmonary sarcoidosis

 Zakaria Haddadi ,  Yousef Almheirat ,  Nada Zizi ,  Mohammed Leknani ,  Siham Nasri ,  Imane Kamaoui ,  Imane Skiker . April 2026, page 67

Acute inflammatory polyradiculoneuritis (Guillain-Barré syndrome)

 Guillaume Nicolas ,  Djillali Annane ,  David Orlikowski . April 2026, page 88